Security key
23254X201
IRONWOOD PHARMACEUTICALS, INC. - Class A common stock, $0.001 par value (CYTH)
CUSIP: 23254X201
Q4 2020 13F Holders as of 31 Dec 2020
- Security type / class
- Equity / Class A common stock, $0.001 par value
- Total 13F shares
- 593,267
- Total 13F value
- $2,581,000
- Share change
- +243,267
- SEC-reported price per share
- $4.35
- Number of holders
- 7
- Value change
- +$1,058,000
- Number of buys
- 6
- Shares outstanding
- 162,993,492
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2020
Institutions
7
Top holders
7
CYTH full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2021
IRONWOOD PHARMACEUTICALS INC SEC filings
IRONWOOD PHARMACEUTICALS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 23254X201
Recent filing periods:
Ownership snapshot
Top reported holders of CYTH - IRONWOOD PHARMACEUTICALS, INC. - Class A common stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
WELLINGTON MANAGEMENT GRO...
Disclosed value leader
WELLINGTON MANAGEMENT GRO...
Comparable rows
15/15
Latest evidence
30 Sep 2020
13F
Lead comparable stake: 14%
Showing 1-6 of 15 holder rows.
Quick read
WELLINGTON MANAGEMENT GROUP LLP leads the comparable SEC ownership view at 14%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens WELLINGTON MANAGEMENT GROUP LLP's linked filing trail.
Comparable ownership
Top 5
WELLINGTON MANAGEMENT GROUP LLP
14%
BROWN CAPITAL MANAGEMENT LLC
12%
VANGUARD GROUP INC
9.6%
BlackRock Finance, Inc.
8.6%
Sarissa Capital Management LP
8.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
14%
|
$200,366,000
22,275,154 shares
|
— | 30 Sep 2020 |
| BROWN CAPITAL MANAGEMENT LLC |
13F
Company
|
12%
|
$180,829,000
20,103,292 shares
|
— | 30 Sep 2020 |
| VANGUARD GROUP INC |
13F
Company
|
9.6%
|
$141,748,000
15,758,418 shares
|
— | 30 Sep 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
8.6%
|
$126,733,000
14,089,184 shares
|
— | 30 Sep 2020 |
| Sarissa Capital Management LP |
13F
Company
|
8.6%
|
$126,289,000
14,040,000 shares
|
— | 30 Sep 2020 |
| STATE STREET CORP |
13F
Company
|
4.9%
|
$71,818,000
7,984,250 shares
|
— | 30 Sep 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
593,267
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2020 vs Q1 2025 Across Filers
Q1 2025 holders
0
Q4 2020 holders
7
Holder diff
7
| Investor | Q1 2025 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q1 2025 value | Q4 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend